MMMoaz O. Moursi

Moaz O. Moursi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Moaz O. Moursi has a total of 45 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Hepatic vena cava syndrome: a case report and literature review

    by Muhammad Zahid, Mohammad Es-Salim, Moaz O Moursi, Nabil Mahmood, Abdel-Naser Elzouki

    Background: Hepatic vena cava syndrome (HVCS) is an uncommon condition, with no prior reports from the Gulf area. In regions with limited resources, where this disease is found, there is a lack of data due to underdiagnosis. HVCS results from recurrent bacterial thrombophlebitis of the hepatic portion of the inferior vena cava (IVC), causing intimal thickening and obstruction, eventually leading to complications like liver cirrhosis and hepatocellular carcinoma. Case presentation: A 32-year-old Afghan refugee lady, presented with progressive abdominal distention. Initial investigations showed anemia, splenomegaly, and massive ascites. Further investigations revealed cirrhotic liver, varices, and a stenotic segment of the IVC. She was diagnosed with HVCS, underwent IVC stenting, and commenced on clopidogrel and dabigatran. Conclusion Often misdiagnosed, HVCS requires a high index of suspicion and should be considered in patients with liver cirrhosis with low socioeconomic backgrounds. Early diagnosis can prevent liver cirrhosis and hepatocellular carcinoma. Key clinical message Often misdiagnosed, Hepatic Vena Cava Syndrome requires a high index of suspicion and should be considered in low socioeconomic backgrounds. Early diagnosis can prevent liver cirrhosis and hepatocellular carcinoma.


  • Open Access

    Sweet Syndrome With Painless Skin Lesions and Myopericarditis: A Case Report and Literature Review

    by Fakhruddin Almuzghi, Islam Elzouki, Moaz O. Moursi, Asiya Aqeel Thakur, Mahir Petkar

    Sweet syndrome is a rare inflammatory disease that typically presents with painful erythematous skin lesions and fever. Although the skin lesions are generally painful on clinical examination, in this case, they were noted to be painless without tenderness. Moreover, our case is unique in that this patient had myopericarditis, a rare extracutaneous manifestation of sweet syndrome.


  • Open Access

    Diagnostic Dilemma: Adult Onset Still’s Disease Mimicking Lymphoma—A Case Report and Literature Review

    by Mohannad N. AbuHaweeleh, Al-Jouhara Albaloshi, Mohammed Al-Hor, Majed Al-Theyab, Ahmad Almaslamani, Basant Elsayed, Moaz O. Moursi, Abdelrahman Hamad

    Introduction: Adult‐onset Still’s disease (AOSD) is a rare systemic inflammatory condition with hallmark features of spiking fevers, arthritis, and a salmon‐colored maculopapular rash. It typically affects young adults, with a bimodal age distribution of 15–25 and 36–46 years. The prevalence of AOSD ranges from 1 to 34 cases per million people, with an incidence rate of 0.16–0.4 per 100,000 individuals. AOSD’s etiology remains unclear but is thought to involve genetic and environmental factors. Diagnosis relies on clinical criteria, such as the Yamaguchi criteria, and exclusion of other conditions. Misdiagnosis is common, particularly in regions where infections and malignancies with overlapping features are prevalent. This case report highlights a diagnostically challenging case of AOSD in a young woman, emphasizing the importance of thorough evaluation and accurate diagnosis. Case Presentation: A 21‐year‐old female with no prior comorbidities presented with persistent fever, a transient salmon‐colored rash, and polyarthritis involving the wrists, shoulders, ankles, and small joints. Three months prior, she had been treated for left submandibular sialadenitis attributed to mumps. Laboratory work revealed elevated C‐reactive protein (CRP), ferritin, and LDH levels with a normal erythrocyte sedimentation rate (ESR) and autoimmune profile. Imaging studies, including PET‐CT, suggested malignancy, raising suspicion of lymphoma. However, lymph node biopsy showed reactive hyperplasia without evidence of malignancy. Ultimately, a diagnosis of AOSD was established based on clinical and laboratory findings. The patient was initiated on anakinra and prednisolone, leading to significant improvement. At a 2‐month follow‐up, she had complete resolution of symptoms. Conclusion: AOSD presents a significant diagnostic challenge due to its rarity and symptom overlap with infections, malignancies, and autoimmune diseases. This case highlights the importance of a thorough clinical evaluation and the application of established diagnostic criteria to facilitate early diagnosis and timely management.


  • Open Access

    Cerebral Venous Sinus Thrombosis Linked to Dietary Supplement Use in a Bodybuilder: A Case Report

    by Sondos K. Khalil, Zahra B. Yousif, Jawaher Baraka, Israa Al‐Hashimi, Moaz O. Moursi, Abdalla Fadul, Wanis Ibrahim

    Many dietary supplements commonly used by bodybuilders and athletes carry thrombogenic risks, potentially leading to life‐threatening conditions like arterial and venous thrombosis by either elevating testosterone levels or directly interfering with homeostasis. Increased awareness and further research are crucial for consumer safety and supplement regulation.

  • Open Access

    Ischemic stroke as an initial presentation of neurosyphilis in a newly diagnosed HIV patient: A case report and literature review

    by Moaz O. Moursi, Wael Hamam, Adnan Hajjar, Mohammad Es‐Salim, Soha Aboukhalaf, Omar Jamil, Muhammad Zahid

    Key Clinical Message: With syphilis resurgence, physicians should be more vigilant to infection‐induced cerebral vasculitis in high‐risk patients presenting with neurological symptoms. In this case, neurosyphilis should not be missed. Thorough serologic screening and lumbar puncture are crucial for diagnosis, and further research is needed for safe and effective treatments in these populations.


  • Open Access

    Coexistence of brain capillary telangiectasia and venous angioma: A case report and literature review

    by Moaz O. Moursi, Anas Alsadi, Yousra Ali, Jouhar Kolleri, Tanweer Hussein

    Key Clinical Message: While Cerebral vascular malformations exhibit distinct clinical and radiographical features, rare instances of coexisting lesions occur. This case report sheds light on the rare coexistence of brain capillary telangiectasia and venous angioma in a patient presenting with a seizure attributed to frontal lobe bleeding. Though often silent, brain capillary telangiectasia can manifest with serious life‐threatening intracranial bleeding. Therefore, in cases of spontaneous intracranial bleeding, an MRI of the head is crucial to rule out such cerebral vascular malformations.


  • Open Access

    The role of anti-Mullerian hormone and other correlates in patients with polycystic ovary syndrome

    by Moaz O. Moursi, Haya Salem, Ayman R. Ibrahim, Sandy Marzouk, Sara Al-Meraghi, Maha Al-Ajmi, Alreem Al-Naimi, Lolwa Alansari

    Anti-Müllerian hormone (AMH) has recently emerged as a promising biomarker for the detection of polycystic ovarian morphology. In polycystic ovary syndrome (PCOS), an elevated level of AMH has been suggested to add value to the Rotterdam criteria in cases of diagnostic uncertainty. In this study, we evaluated the correlation between AMH and PCOS, and the potential role of AMH in PCOS diagnosis. A case-control study was performed on a total of 200 females, 100 of which were diagnosed with PCOS as per Rotterdam revised criteria (2003) and 100 as the control (non-PCOS group). Patient medical records were therefore retrieved for clinical, biochemical and ultrasound markers for PCOS diagnosis. Sensitivity, specificity, area under receiver operating characteristic (AUROC) curve, and multivariate linear regression models were applied to analyze our data. Mean serum levels of LH and AMH, and LH/FSH ratio were significantly different between compared groups. In the PCOS group, the mean serum AMH level was 6.78 ng/mL and LH/FSH ratio was 1.53 while those of controls were 2.73 ng/mL and 0.53, respectively (p < .001). The most suitable compromise between 81% specificity and 79% sensitivity was obtained with a cutoff value of 3.75 ng/mL (26.78 pmol/L) serum AMH concentration for PCOS prediction, with an AUROC curve of 0.9691. Serum AMH cutoff level of 3.75 ng/mL was identified as a convenient gauge for the prediction of PCOS and an adjuvant to the Rotterdam criteria.


  • Abstract #1316108: The Role of Anti-Mullerian Hormone and Other Correlates in Polycystic Ovary Syndrome Patients

    by Moaz Moursi, Ayman Ibrahim, Haya Salem, Sandy Marzouk, Sara Al-Meraghi, Maha Al-Ajmi, Alreem Al-Naimi, Lolwa Alansari

  • Open Access

    The Association between Early Opioids Prescribing and the Length of Disability in Acute Lower Back Pain: A Systematic Review and Narrative Synthesis

    by Ayman R. Ibrahim, Mohamed E. Elgamal, Moaz O. Moursi, Bara A. Shraim, Muath A. Shraim, Mujahed Shraim, Basem Al-Omari

    Background: There is conflicting evidence with respect to whether early opioid prescribing (EOP) within the first two weeks of acute Low Back Pain (LBP) onset is associated with the length of disability (LOD). The aim of this systematic review was to examine the relationship between EOP and LOD in individuals with acute LBP. Methods: A systematic search of Medline, EMBASE, and CINAHL was conducted. The Newcastle–Ottawa scale was used to assess the methodological quality of included studies. A narrative synthesis of findings was used owing to between-study heterogeneity. Results: Six cohort studies using workers’ compensation administrative data on 178,130 adults with LBP were included. Most studies were of good methodological quality. One study reported that LBP cases with EOP had higher LOD by 4 days than cases without EOP. Two studies reported that each 100 mg morphine equivalent amount (MEA) was associated with an increase in mean LOD by 0.4 day (95% confidence interval (CI): 0.3, 0.5) and 0.4 day (95% CI: 0.3, 0.4). One study showed that LBP cases with EOP had a higher hazard of continuation of time loss benefits by 1.94 (95% CI 1.86, 2.02). One study reported a dose–response relationship between MEA of EOP and LOD ranging between 5.2 days (95% CI 14.6, 25.0) for 1–140 mg MEA and 69.1 (95% CI 49.3, 89.0) for 450+ mg MEA. One study reported that LBP cases with EOP had a higher mean LOD by 3.8 days, but there was no statistically significant relationship between EOP and LOD (Hazard ratio 1.02; 95% CI 0.91, 1.13). Conclusions: The use of early opioid in the management of acute uncomplicated LBP is associated with prolonged disability duration. Further research on factors influencing inadequate adherence to evidence-based guidelines and optimal strategies to modify such factors may improve disability outcomes among patients presenting with acute LBP.